Stock VAXX VAXXINITY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Vaxxinity, Inc.

Equities

VAXX

US92244V1044

Market Closed - Nasdaq
Other stock markets
 21:30:01 03/05/2024 BST 		5-day change 1st Jan Change
0.1411 USD +35.41% Intraday chart for Vaxxinity, Inc. +21.01% -83.40%
04-22 Sector Update: Health Care Stocks Advance Premarket Monday MT
04-22 Sector Update: Health Care MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Vaxxinity Issues Shareholder Letter
AQ
Vaxxinity Issues Shareholder Letter
GL
Vaxxinity Announces Intention to Voluntarily Delist and Deregister its Class A Common Stock
GL
Vaxxinity to Present Clinical Data at the Annual Academy of Neurology 2024 Annual Meeting
GL
Vaxxinity Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Updates
GL
Vaxxinity : UB-312 Target Engagement - ADPD 2024
PU
Vaxxinity Announces Positive Target Engagement Data from Phase 1 Clinical Trial for Parkinson’s Disease at AD/PD™ 2024
GL
Vaxxinity’s Cholesterol Vaccine Candidate Successfully Lowers LDL-C: Preclinical Data Published
GL
Vaxxinity to Present Clinical and Preclinical Pipeline Data at AD/PD 2024
GL
Vaxxinity to Present Clinical and Preclinical Pipeline Data at AD/PD 2024
AQ
Vaxxinity Announces Research Collaboration on Active Immunotherapies for Neurodegenerative Diseases with University of Florida
GL
Vaxxinity Announces Research Collaboration on Active Immunotherapies for Neurodegenerative Diseases with University of Florida
AQ
Vaxxinity Announces Collaboration on Space Medicine Research with University of Central Florida
GL
Vaxxinity Announces Collaboration on Space Medicine Research with University of Central Florida
AQ
Vaxxinity to Present at the 2024 J.P. Morgan Healthcare Conference
GL
Vaxxinity to Present at Upcoming November Medical and Investor Conferences
GL
Vaxxinity to Present at Upcoming November Medical and Investor Conferences
AQ
Vaxxinity Reports Third Quarter 2023 Financial Results and Provides Corporate Update
GL
Vaxxinity Reports Third Quarter 2023 Financial Results and Provides Corporate Update
AQ
Vaxxinity : H.C. Wainwright 25th Annual Global Investment Conference
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VAXX Stock
  4. News Vaxxinity, Inc.
  5. Press Releases